Effect of singing lessons on physical activity in patients with Chronic Obstructive Pulmonary Disease (COPD)

ISRCTN ISRCTN39714922
DOI https://doi.org/10.1186/ISRCTN39714922
Secondary identifying numbers V3
Submission date
22/11/2010
Registration date
25/11/2010
Last edited
11/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nicholas Hopkinson
Scientific

Royal Brompton Hospital
Fulham Rd
London
SW3 6NP
United Kingdom

Study information

Study designSingle-blind prospective randomised controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet
Scientific titleEffect of singing lessons on physical activity in patients with COPD: a prospective, single-blind, randomised controlled trial
Study objectivesThat 8 weeks of twice weekly vocal coaching will improve daily physical activity in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to a control group taking part in a film club.
Ethics approval(s)The Brompton, Harefield & NHLI Research Ethics Committee, 15/12/2009, ref: 07/H0708/900
Health condition(s) or problem(s) studiedChronic Obstructive Pulmonary Disease (COPD)
InterventionPatients will be randomised to receive either:
1. Singing lessons twice per week for 8 weeks
2. Film club once per week for 8 weeks

Participants will be followed for 1 week after the end of the program.
Intervention typeOther
Primary outcome measureDaily physical activity assessed using the SenseWear armband at one week after the end of the program
Secondary outcome measures1. Hospital Anxiety Depression (HAD) score
2. COPD Assessment Test (CAT) score
3. Shuttle walk distance
All outcomes will be assessed 1 week after the end of the program
Overall study start date01/12/2010
Completion date01/05/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants30
Key inclusion criteria1. Patients with COPD with MRC dyspnea score >3/5
2. Either sex, aged >21 years
Key exclusion criteria1. Patients with a life expectancy of <3 months
2. Patients where a diagnosis of primary hyperventilation has been made i.e. with normal lung function test results
3. Other co-morbidities will be permitted unless they are likely to interfere directly with participation in the study
Date of first enrolment01/12/2010
Date of final enrolment01/05/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal Brompton Hospital
London
SW3 6NP
United Kingdom

Sponsor information

Imperial College London (UK)
University/education

c/o Gary Roper
G02 SAF Building
S Ken Campus
London
SW7 2AZ
England
United Kingdom

ROR logo "ROR" https://ror.org/041kmwe10

Funders

Funder type

Government

National Institute of Health Research (NIHR) Respiratory Biomedical Research Unit (BRU) (UK) - run jointly by:

No information available

Royal Brompton & Harefield NHS Foundation Trust (UK)

No information available

Imperial College London, National Heart & Lung Institute (NHLI) (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 13/11/2012 Yes No